Study data indicate that women who ate a Western diet also had 46 percent higher risk of breast cancer.
The definition of dense breasts can range from 6.3 to 84.5 percent of patients, depending on radiologist.
Both automated and clinical assessments of breast density are associated with breast cancer risk.
Diabetes treatments, such as diet or pills (eg, metformin), decrease mammographic density, whereas insulin may increase mammographic density.
Breast density assessments can vary for as many as 19% of women, which can lead to inconsistent information regarding the need for additional clinical screenings.
Not all women with dense breasts have a high enough breast cancer risk to justify additional imaging after a normal mammogram, according to a recent study.
Five-year risk plus breast density can best identify women at high risk for interval cancer.
Lowest variability seen in Volpara and Quantra; higher variability for Cumulus ABD and CumulusV methods.
A low degree of mammographic breast density worsens the prognosis of breast cancer, according to a recent study.
Disparities exist regarding the level of awareness and knowledge of breast density among US women, according to a study.
Half of primary care physicians are still unfamiliar with the California law mandating that clinicians notify women with dense breast tissue, and many do not feel comfortable answering breast density-related questions.
Semiautomated computer-derived measurements are consistent with radiologist assessments, according to a study.
Automated breast density measurement is predictive of breast cancer risk in younger women, and that risk may be related to the rate at which breast density changes in some women as they age, according to research.
Mammographic density is associated with breast cancer among women younger than 50 years, according to a study.
A website has been developed to help navigate the new challenges posed by breast-density notification laws, according to a recent special report.
HRT-linked risk up for white, Asian, Hispanic women; for low/normal BMI and dense breasts.
For women treated with tamoxifen, decrease in mammographic density tied to improved survival.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- LIVESTRONG Exercise Program Improves QoL in Cancer Survivors
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
- Profile of Tivantinib and its Potential in the Treatment of Hepatocellular Carcinoma: the evidence to date
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|